Blog Where innovation, insight & ideas combine. Contact Us Ask The Experts Home Blog Translational Pharmaceutics, Dr. Helen Baker, Dr. Vanessa Zann, Drug Development Consulting, Drug Product, Philadelphia, Miami Accelerating Drug Development with Translational Pharmaceutics® Read Now Categories View all categories14C Radiolabeling505(b)(2)AlnwickBioanalysisBiopharmaceuticsBlogCandidate DevelopmentCandidate SelectionCareersClinical PharmacologyClinical Trial ManufacturingClinical Trial SuppliesColleague StoriesCommercial ManufacturingCorporate UpdatesCRDMOData SciencesDenise SuttonDennis HendersonDr. Adam Robinson-MillerDr. Andrew LewisDr. Aruna RailkarDr. Asma PatelDr. Gareth JenkinsDr. Helen BakerDr. Peter ScholesDr. Richard Castledine Dr. Stuart MairDr. Stuart McDougallDr. Vanessa ZannDrug Development ConsultingDrug ProductDrug Product OptimizationDrug Substance to Drug ProductEarly DevelopmentFirst-in-HumanFormulation DevelopmentFreeThink ASAPprimeGamma ScintigraphyGLP-1 TherapeuticsHealthy Volunteer TrialsHelen BakerHigh Potency APIsHuman ADMEIain ShawIan NisbetICP-MSIndustry CollaborationInhalationJohn EntwistleJohn McDermottKevser SevimLate DevelopmentMartin Wing-KingMiamiMicrobiologyModeling and SimulationModified ReleaseNazim KanjiNichole CaparelliNottinghamOmer AlpOncologyOrphan DrugsOrphan RarePaige BellisPediatricsPeptidesPharmacy CompoundingPhase 1 TrialsPhiladelphiaPR&DProject ManagementQuality AssuranceRare DiseasesReadingRegulatoryScientific AchievementsScientific InnovationScintigraphySite SpotlightSolid-State CharacterizationSolubility EnhancementThierry Van NieuwenhoveDrug SubstanceIntegrated ProgramsSustainabilityTranslational Pharmaceutics Publish Date View all time20252024202320222021202020192018 Fulltext search 11 - 15 of 121 results Translational Pharmaceutics, Denise Sutton, Nottingham, Clinical PharmacologySpotlight on Nottingham: Q&A with Denise Sutton, Chief Operating Officer and Site Head - Nottingham, UK – Part 1 Translational Pharmaceutics, Denise Sutton, Nottingham, Clinical PharmacologySpotlight on Nottingham: Q&A with Denise Sutton, Chief Operating Officer and Site Head - Nottingham, UK – Part 1 Learn more Modified Release, Dr. Helen Baker, FreeThink ASAPprimeObtaining rapid stability data through ASAPprime®: Q&A with Helen Baker Modified Release, Dr. Helen Baker, FreeThink ASAPprimeObtaining rapid stability data through ASAPprime®: Q&A with Helen Baker Learn more Peptides, Dr. Andrew Lewis, GLP-1 TherapeuticsInterview with Dr. Andy Lewis: On GLP-1 Agonists and Overcoming CMC Challenges of Oral Peptide Drug Development Peptides, Dr. Andrew Lewis, GLP-1 TherapeuticsInterview with Dr. Andy Lewis: On GLP-1 Agonists and Overcoming CMC Challenges of Oral Peptide Drug Development Learn more Peptides, Dr. Andrew Lewis, Dr. Stuart Mair, GLP-1 TherapeuticsUnlocking the Potential of GLP-1 Agonists: Q&A with Dr. Andrew Lewis and Dr. Stuart Mair Peptides, Dr. Andrew Lewis, Dr. Stuart Mair, GLP-1 TherapeuticsUnlocking the Potential of GLP-1 Agonists: Q&A with Dr. Andrew Lewis and Dr. Stuart Mair Learn more Drug Substance, Dr. Richard Castledine How Can Drug Developers Overcome API Synthesis Challenges in Drug Development? Drug Substance, Dr. Richard Castledine How Can Drug Developers Overcome API Synthesis Challenges in Drug Development? Learn more Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 … Next page Next › Last page Last » Learn more about Quotient Sciences At a Glance We are a drug development and manufacturing accelerator for the global pharmaceutical industry. Learn More Our Locations Access directions and information about our facilities in the US & UK. Browse Locations Careers See what life is like at Quotient Sciences and how you can join our global team. Browse Jobs Get in touch Humanity can't afford to wait, so neither can we. Let's talk
